RYVESTA Trademark

Trademark Overview


On Tuesday, April 11, 2017, a trademark application was filed for RYVESTA with the United States Patent and Trademark Office. The USPTO has given the RYVESTA trademark a serial number of 87406461. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 20, 2023. This trademark is owned by Novartis AG. The RYVESTA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the preve...
ryvesta

General Information


Serial Number87406461
Word MarkRYVESTA
Filing DateTuesday, April 11, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
Translation of Words in MarkThe wording "RYVESTA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 18, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Tuesday, February 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 21, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 3, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, June 26, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 13, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 13, 2019ASSIGNED TO LIE
Wednesday, October 30, 2019ASSIGNED TO EXAMINER
Monday, May 13, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, November 13, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, May 10, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 27, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 27, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 27, 2017LETTER OF SUSPENSION E-MAILED
Thursday, April 27, 2017SUSPENSION LETTER WRITTEN
Thursday, April 27, 2017ASSIGNED TO EXAMINER
Tuesday, April 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 14, 2017NEW APPLICATION ENTERED